10x Genomics is a life science technology company. Co.'s integrated platform solutions include instruments, consumables and software. Co.'s commercial product portfolio utilizes its Chromium X Series and Chromium Connect, its Visium CytAssist, an instrument designed to simplify the Visium solution workflow, its Xenium Analyzer, an instrument designed for high-throughput analysis of cells in their tissue environment, and its proprietary microfluidic chips, slides, reagents and other consumables for its Chromium, Visium and Xenium solutions. Co. bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization. We show 17 historical shares outstanding datapoints in our TXG shares outstanding history coverage, used to compute TXG market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing TXG market cap history over the course of time is important for investors
interested in comparing TXG's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of TXG versus a peer is one thing; comparing
TXG market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like TXG can fluctuate over the course of history.
With this page we aim to empower investors researching TXG by allowing them to research the TXG market cap history. |
Free TXG Email Alerts:
Video: The Importance of Market Cap
